Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leading-edge Research Center for Drug Discovery (LERC) is a specialized research entity primarily associated with Astellas Pharma, focused on pioneering new therapeutic modalities. The center concentrates on high-potential areas such as cell and gene therapy, as well as innovative small molecule discovery. LERC operates as a hub for advanced R&D, utilizing cutting-edge technologies to address unmet medical needs in oncology, ophthalmology, and muscle-related disorders. By integrating diverse scientific disciplines, the center aims to accelerate the transition from basic research to clinical application. Its work is central to the long-term innovation strategy of its parent organization, fostering collaborations with academic and industrial partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leading-edge Research Center for Drug Discovery.